User talk:Scarter2011
Welcome
|
Speedy deletion nomination of Martin Shkreli
If this is the first article that you have created, you may want to read the guide to writing your first article.
You may want to consider using the Article Wizard to help you create articles.
A tag has been placed on Martin Shkreli, requesting that it be speedily deleted from Wikipedia. This has been done under section G11 of the criteria for speedy deletion, because the page seems to be unambiguous advertising which only promotes a company, product, group, service or person and would need to be fundamentally rewritten in order to become an encyclopedia article. Please read the guidelines on spam and Wikipedia:FAQ/Business for more information.
If you think that this notice was placed here in error, contest the deletion by clicking on the button labelled "Click here to contest this speedy deletion". Doing so will take you to the talk page where you will find a pre-formatted place for you to explain why you believe the page should not be deleted. You can also visit the page's talk page directly to give your reasons, but be aware that once tagged for speedy deletion, if the page meets the criterion, it may be deleted without delay. Please do not remove the speedy deletion tag yourself, but don't hesitate to add information to the page that would render it more in conformance with Wikipedia's policies and guidelines. If the page is deleted, you can contact one of these administrators to request that the administrator userfy the page or email a copy to you. Night of the Big Wind talk 10:53, 14 November 2011 (UTC)
Status and Advice
As reviewing administrator, I decided not to delete the article, because while it was substantially promotional for Skrell, his hedge fund, and espewcially his pharmaceutical company, it could be fixed by a little editing, some of which I did.
On the talk p, you said
- "This page is not unambiguously promotional, because it contains a number of references from the highest level business journals/newspapers, in particular Bloomberg and the Financial Times, verifying the hedge fund manager's noteworthiness. Secondly, this page is very much in line with other hedge fund manager Wikipedia pages, such as those of Paul Singer, or Marc Lasry. In fact, this page was meticulously prepared with an eye to how Singer's page was crafted in order to pass muster with Wikipedia. It describes a noteworthy person, and that person's achievements, with all achievements footnoted. The company that the person did create has 282 Associated News articles on the company, as noted on BioPortfolio, which suggests the noteworthiness of the individual. There is no outward promotion of the individual on the page; it is simply a statement of facts of the individual's life and pursuits, which have garnered considerable press in major Associated Press journals and news articles. To delete such an article for promotion "of a product or person" would be incorrect because this individual is not a product, and the page does not promote the person -- it simply states referenced facts. --Scarter2011 (talk) 13:13, 14 November 2011 (UTC)
But WP will delete a page that is exclusively promotional about anything, whether or not the ostensible subject of an article. If it tries to promote a person's business interests, it's promotional. The evasiveness above is irrelevant. It was indeed quite promotional about the drug company, using vague terms of praise about their efforts, calling it a leading firm when it was founded only in 2011, and failing to make it clear that what appears to be its sole drug that has reached the stage of regulatory approval is not yet approved. But I was able to remove the promotional elements, by normal editing.
Not all your references are usable. The Bloomberg one is a good reference. I am not able to see the FT article, nor will most readers, so you need to give some indication that its substantial (page numbers, perhaps a one-sentence quotation that includes his name.) The BWeek page is mere directory information; it's needed as a reference, for lack of anything else about the drug company, but does not show notability. The article of Robertson is irrelevant here, for it does not mention him, and I removed it: information about Robertson will be found in his own article. The Biotechnology page is that of a news aggregator: please cite whatever individual articles are references providing substantial coverage from 3rd party independent published reliable sources, print or online, but not blogs or press releases, or material derived from press releases. DGG ( talk ) 22:40, 15 November 2011 (UTC)